Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 87 articles:
HTML format
Text format



Single Articles


    March 2018
  1. EL-SHERIF O, Jiang ZG, Tapper EB, Huang KC, et al
    Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30314.
    PubMed     Text format     Abstract available


  2. LO GH
    The Elevation of Hepatic Venous Pressure Gradient After Sustained Virologic Response in Hepatitis C Virus-Related Cirrhosis.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30148.
    PubMed     Text format    


  3. PONZETTO A, Figura N
    Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30153.
    PubMed     Text format    


  4. HARVEY LD, Chan SY
    YAPping About Glutaminolysis in Hepatic Fibrosis.
    Gastroenterology. 2018 Mar 3. pii: S0016-5085(18)30259.
    PubMed     Text format    


    February 2018
  5. TZARTZEVA K, Obi J, Rich NE, Parikh ND, et al
    Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30155.
    PubMed     Text format     Abstract available


    January 2018
  6. SIMON-TALERO M, Roccarina D, Martinez J, Lampichler K, et al
    Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Gastroenterology. 2018 Jan 20. pii: S0016-5085(18)30069.
    PubMed     Text format     Abstract available


  7. MANCUSO A, Politi F, Maringhini A
    Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36673.
    PubMed     Text format    


  8. WOOD CP, Rowe IA
    What Are the Benefits of Anticoagulation for Portal Vein Thrombosis in Individuals With Cirrhosis?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36671.
    PubMed     Text format    


  9. CHEN H, Lv Y, Han G
    Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: Not Only Recanalize the Portal Vein.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36672.
    PubMed     Text format    


  10. QI X, Valla DC, Guo X
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36669.
    PubMed     Text format    


    October 2017
  11. JOHN M, Metwally M, Mangia A, Romero-Gomez M, et al
    TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.
    Gastroenterology. 2017 Oct 6. pii: S0016-5085(17)36134.
    PubMed     Text format    


    July 2017
  12. LENS S, Alvarado E, Marino Z, Londono MC, et al
    Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.
    Gastroenterology. 2017 Jul 19. pii: S0016-5085(17)35922.
    PubMed     Text format     Abstract available


  13. KING A, Houlihan DD, Kavanagh D, Haldar D, et al
    Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
    Gastroenterology. 2017;153:233-248.
    PubMed     Text format     Abstract available


  14. KHAMRI W, Abeles RD, Hou TZ, Anderson AE, et al
    Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.
    Gastroenterology. 2017;153:263-276.
    PubMed     Text format     Abstract available


    June 2017
  15. KANWAL F, Kramer J, Asch SM, Chayanupatkul M, et al
    Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35797.
    PubMed     Text format     Abstract available


  16. CANNON MD, Heneghan MA
    Endoscopy in Pregnant Women with Liver Cirrhosis.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35602.
    PubMed     Text format    


    May 2017
  17. LOFFREDO L, Pastori D, Farcomeni A, Violi F, et al
    Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: a Systematic Review and Meta-Analysis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35552.
    PubMed     Text format     Abstract available


  18. KHAN MA, Cholankeril G, Howden CW
    Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35404.
    PubMed     Text format    


  19. ASSARAF J, Weiss N, Thabut D
    Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35403.
    PubMed     Text format    


  20. SINGH S, Muir AJ, Dieterich DT, Falck-Ytter YT, et al
    American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Gastroenterology. 2017;152:1544-1577.
    PubMed     Text format     Abstract available


  21. LAI KKY, Kweon SM, Chi F, Hwang E, et al
    Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
    Gastroenterology. 2017;152:1477-1491.
    PubMed     Text format     Abstract available


    April 2017
  22. AN SY, Jang YJ, Lim HJ, Han J, et al
    Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
    Gastroenterology. 2017;152:1174-1186.
    PubMed     Text format     Abstract available


    March 2017
  23. JACOBSON IM, Lim JK, Fried MW
    AGA Institute Clinical Practice Update: Care of Patients Who Have Achieved a Sustained Virologic Response (SVR) Following Antiviral Therapy for Chronic Hepatitis C Infection.
    Gastroenterology. 2017 Mar 23. pii: S0016-5085(17)30327.
    PubMed     Text format     Abstract available


  24. MANCUSO A
    Classification of Portal Vein Thrombosis in Cirrhosis.
    Gastroenterology. 2017 Mar 3. pii: S0016-5085(17)30135.
    PubMed     Text format    


    February 2017
  25. JACOBSON IM, Lawitz E, Kwo PY, Hezode C, et al
    Safety and Efficacy of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Infection and Compensated Cirrhosis: an Integrated Analysis.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30150.
    PubMed     Text format     Abstract available


  26. MATSUURA K, Sawai H, Ikeo K, Ogawa S, et al
    Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Gastroenterology. 2017 Feb 2. pii: S0016-5085(17)30130.
    PubMed     Text format     Abstract available


  27. RAVI S, Axley P, Jones D, Kodali S, et al
    Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Gastroenterology. 2017 Feb 1. pii: S0016-5085(16)35535.
    PubMed     Text format    


  28. PARK CC, Nguyen P, Hernandez C, Bettencourt R, et al
    Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2017;152:598-607.
    PubMed     Text format     Abstract available


    January 2017
  29. GOLDBERG D, Ditah IC, Saeian K, Lalehzari M, et al
    Changes in the Prevalence of Hepatitis C Virus Infection, Non-alcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30014.
    PubMed     Text format     Abstract available


    November 2016
  30. SINGAL AG, Tiro JA, Marrero JA, McCallister K, et al
    Mailed Outreach Program Increases Ultrasound Screening of Patients with Cirrhosis for Hepatocellular Carcinoma.
    Gastroenterology. 2016 Nov 5. pii: S0016-5085(16)35321.
    PubMed     Text format     Abstract available


    October 2016
  31. WEERSINK RA, Drenth JP, Borgsteede SD
    Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced Cirrhosis.
    Gastroenterology. 2016 Oct 3. pii: S0016-5085(16)35074.
    PubMed     Text format    


  32. LO GH
    Did Statins Really Improve Survival in Cirrhotic Patients With a History of Variceal Bleeding?
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35075.
    PubMed     Text format    


    September 2016
  33. BUREAU C, Thabut D, Oberti F, Dharancy S, et al
    Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Gastroenterology. 2016 Sep 20. pii: S0016-5085(16)35110.
    PubMed     Text format     Abstract available


  34. NAHON P, Bourcier V, Layese R, Audureau E, et al
    Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
    Gastroenterology. 2016 Sep 15. pii: S0016-5085(16)35070.
    PubMed     Text format     Abstract available


  35. TSAI CF, Chen MH, Wang YP, Chu CJ, et al
    Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in Population Study.
    Gastroenterology. 2016 Sep 14. pii: S0016-5085(16)35032.
    PubMed     Text format     Abstract available


    August 2016
  36. KALMAN RS, Goldberg DS
    Obeticholic Acid Reduces Bacterial Translocation and Inhibits Intestinal Inflammation in Cirrhotic Rats.
    Gastroenterology. 2016 Aug 28. pii: S0016-5085(16)34977.
    PubMed     Text format    


  37. SARIN SK, Philips CA, Kamath PS, Choudhary A, et al
    Towards a Comprehensive New Classification of Portal Vein Thrombosis in Patients with Cirrhosis: A Commentary.
    Gastroenterology. 2016 Aug 26. pii: S0016-5085(16)34975.
    PubMed     Text format    


  38. TERRAULT NA, Zeuzem S, Di Bisceglie AM, Lim JK, et al
    Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated of Sustained Virologic Response.
    Gastroenterology. 2016 Aug 23. pii: S0016-5085(16)34927.
    PubMed     Text format     Abstract available


    July 2016
  39. GANE E, Poordad F, Wang S, Asatryan A, et al
    High Efficacy of ABT-493 and ABT-530 in Patients with HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34816.
    PubMed     Text format     Abstract available


  40. SHIN JY, Azoulay L, Filion KB
    Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias?
    Gastroenterology. 2016 Jul 1. pii: S0016-5085(16)34434.
    PubMed     Text format    


    June 2016
  41. IOANNOU GN, Beste LA, Chang MF, Green PK, et al
    Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Healthcare System.
    Gastroenterology. 2016 Jun 4. pii: S0016-5085(16)34575.
    PubMed     Text format     Abstract available


    May 2016
  42. GANE EJ, Schwabe C, Hyland RH, Yang Y, et al
    Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-naive or Previously Treated Patients with HCV Genotype 1 or 3 Infections.
    Gastroenterology. 2016 May 27. pii: S0016-5085(16)34513.
    PubMed     Text format     Abstract available


  43. MANCINA RM, Dongiovanni P, Petta S, Pingitore P, et al
    The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Gastroenterology. 2016;150:1219-1230.
    PubMed     Text format     Abstract available


    April 2016
  44. PALMER RH
    Biliary Cirrhosis Treated With Ursodeoxycholic Acid.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00363.
    PubMed     Text format    


  45. GINES P
    Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Telipressin and Beyond.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)34324.
    PubMed     Text format    


  46. BARRESI L, Ligresti D, Traina M
    A Challenging Diagnosis for a Biliary Stricture.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00215.
    PubMed     Text format    


  47. CALDERONE V, Gallego J, Fernandez-Miranda G, Garcia-Pras E, et al
    Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
    Gastroenterology. 2016;150:982-97.
    PubMed     Text format     Abstract available


    March 2016
  48. DI MARCO V, Calvaruso V, Ferraro D, Bavetta MG, et al
    Effects of Viral Eradication in Patients with HCV and Cirrhosis Differ With Stage of Portal Hypertension.
    Gastroenterology. 2016 Mar 31. pii: S0016-5085(16)30049.
    PubMed     Text format     Abstract available


  49. CHIN JL, Chan G, Ryan JD
    Noninvasive Assessment of Liver Fibrosis and Cirrhosis With Ultrasound-based Elastography in Alcohol-related Liver Disease.
    Gastroenterology. 2016 Mar 25. pii: S0016-5085(16)00301.
    PubMed     Text format    


  50. NEPHEW LD, Goldberg DS
    Impact of Anticoagulation on Upper Gastrointestinal Bleeding in Cirrhosis.
    Gastroenterology. 2016 Mar 24. pii: S0016-5085(16)00377.
    PubMed     Text format    


  51. ROCKEY DC
    A new treatment for portal hypertension?
    Gastroenterology. 2016 Mar 23. pii: S0016-5085(16)00368.
    PubMed     Text format    


  52. LASSAILLY G, Caiazzo R, Pattou F, Mathurin P, et al
    Perspectives on Treatment for Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Mar 10. pii: S0016-5085(16)00323.
    PubMed     Text format     Abstract available


  53. TAOULI B, Serfaty L
    Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2016;150:553-6.
    PubMed     Text format    


  54. IMAJO K, Kessoku T, Honda Y, Tomeno W, et al
    Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Gastroenterology. 2016;150:626-637.
    PubMed     Text format     Abstract available


    February 2016
  55. BOYER TD, Sanyal AJ, Wong F, Frederick RT, et al
    Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1.
    Gastroenterology. 2016 Feb 16. pii: S0016-5085(16)00217.
    PubMed     Text format     Abstract available


  56. RATZIU V, Harrison S, Francque S, Bedossa P, et al
    Elafibranor, an Agonist of the Peroxisome Proliferator-activated Receptor-alpha and -delta, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
    Gastroenterology. 2016 Feb 10. pii: S0016-5085(16)00140.
    PubMed     Text format     Abstract available


  57. SERFATY L
    Clinical implications of concomitant alcohol use, obesity and viral hepatitis.
    Gastroenterology. 2016 Feb 9. pii: S0016-5085(16)00139.
    PubMed     Text format    


    January 2016
  58. ABRALDES JG, Villanueva C, Aracil C, Turnes J, et al
    Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.
    Gastroenterology. 2016 Jan 13. pii: S0016-5085(16)00043.
    PubMed     Text format     Abstract available


  59. HIRSOVA P, Ibrahim SH, Krishnan A, Verma VK, et al
    Lipid-induced Signaling Causes Release of Inflammatory Extracellular Vesicles from Hepatocytes.
    Gastroenterology. 2016 Jan 4. pii: S0016-5085(15)01865.
    PubMed     Text format     Abstract available


  60. LIANGPUNSAKUL S, Crabb DW
    Early Detection of Alcoholic Liver Disease: Are We a Step Closer?
    Gastroenterology. 2016;150:29-31.
    PubMed     Text format    


    November 2015
  61. MU X, Pradere JP, Affo S, Dapito DH, et al
    Epithelial Transforming Growth Factor-beta Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Gastroenterology. 2015 Nov 25. pii: S0016-5085(15)01721.
    PubMed     Text format     Abstract available


    October 2015
  62. WHITE DL, Richardson P, Tayoub N, Davila JA, et al
    The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.
    Gastroenterology. 2015 Oct 28. pii: S0016-5085(15)01435.
    PubMed     Text format    


  63. MOHANTY A, Tate J, Garcia-Tsao G
    Statins are Associated with a Decreased Risk of Decompensation and Death in Veterans with Hepatitis C-related Compensated Cirrhosis.
    Gastroenterology. 2015 Oct 17. pii: S0016-5085(15)01476.
    PubMed     Text format     Abstract available


  64. THIELE M, Detlefsen S, Sevelsted Moller L, Madsen BS, et al
    Transient and 2-dimensional Shear-Wave Elastography provide comparable assessment of Alcoholic Liver Fibrosis and Cirrhosis.
    Gastroenterology. 2015 Oct 1. pii: S0016-5085(15)01426.
    PubMed     Text format     Abstract available


  65. KOO JH, Lee HJ, Kim W, Kim SG, et al
    Endoplasmic Reticulum Stress in Hepatic Stellate Cells Promotes Liver Fibrosis via PERK-mediated Degradation of HNRNPA1 and Upregulation of SMAD2.
    Gastroenterology. 2015 Oct 1. pii: S0016-5085(15)01425.
    PubMed     Text format     Abstract available


    September 2015
  66. BAJAJ JS
    Diagnosing Minimal Hepatic Encephalopathy: From the Ivory Tower to the Real World.
    Gastroenterology. 2015 Sep 25. pii: S0016-5085(15)01384.
    PubMed     Text format    


  67. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.
    Gastroenterology. 2015 Sep 15. pii: S0016-5085(15)01199.
    PubMed     Text format    


  68. GARCIA-PAGAN JC, Patch D
    Trials and Tribulations: The Prevention of Variceal Rebleeding.
    Gastroenterology. 2015;149:528-31.
    PubMed     Text format    


  69. DU PLESSIS J, van Pelt J, Korf H, Mathieu C, et al
    Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2015;149:635-48.
    PubMed     Text format     Abstract available


  70. XANTHAKOS SA, Jenkins TM, Kleiner DE, Boyce TW, et al
    High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.
    Gastroenterology. 2015;149:623-34.
    PubMed     Text format     Abstract available


    August 2015
  71. AMPUERO J, Simon M, Montoliu C, Jover R, et al
    Minimal Hepatic Encephalopathy and Critical Flicker Frequency are Associated With Survival of Patients With Cirrhosis.
    Gastroenterology. 2015 Aug 20. pii: S0016-5085(15)01176.
    PubMed     Text format     Abstract available


  72. LOOMBA R, Schork N, Chen CH, Bettencourt R, et al
    Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.
    Gastroenterology. 2015 Aug 20. pii: S0016-5085(15)01179.
    PubMed     Text format     Abstract available


  73. LAMMERS WJ, Hirschfield GM, Corpechot C, Nevens F, et al
    Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
    Gastroenterology. 2015 Aug 7. pii: S0016-5085(15)01094.
    PubMed     Text format     Abstract available


  74. BESTE LA, Leipertz SL, Green PK, Dominitz JA, et al
    Trends in the burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US Veterans from 2001-2013.
    Gastroenterology. 2015 Aug 5. pii: S0016-5085(15)01088.
    PubMed     Text format     Abstract available


  75. FOSTER GR, Pianko S, Brown A, Forton D, et al
    Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-alfa in Patients With HCV Genotype 3 Infection and Treatment-Experienced Patients with Cirrhosis and HCV Genotype 2 Infection.
    Gastroenterology. 2015 Aug 3. pii: S0016-5085(15)01069.
    PubMed     Text format     Abstract available


  76. HIRSCHFIELD GM
    Reply.
    Gastroenterology. 2015;149:508-9.
    PubMed     Text format    


  77. LOOMBA R, Chalasani N
    The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH.
    Gastroenterology. 2015;149:278-81.
    PubMed     Text format    


  78. ANGULO P, Kleiner DE, Dam-Larsen S, Adams LA, et al
    Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2015;149:389-97.
    PubMed     Text format     Abstract available


    July 2015
  79. MEHTA A, Singal AG
    Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?
    Gastroenterology. 2015 Jul 28. pii: S0016-5085(15)01012.
    PubMed     Text format    


  80. KOFF RS
    Cirrhosis: A Practical Guide to Management.
    Gastroenterology. 2015 Jul 25. pii: S0016-5085(15)01011.
    PubMed     Text format    


  81. LAWITZ E, Makara M, Akarca US, Thuluvath PJ, et al
    Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-label Study of Patients With Genotype 1b Chronic Hepatitis C Virus, With and Without Cirrhosis.
    Gastroenterology. 2015 Jul 10. pii: S0016-5085(15)00936.
    PubMed     Text format     Abstract available


    June 2015
  82. DONG R, Zheng S, Chen G
    The Appropriate Timing and Dose of Obeticholic Acid in Patients With Primary Biliary Cirrhosis.
    Gastroenterology. 2015 Jun 29. pii: S0016-5085(15)00864.
    PubMed     Text format    


    May 2015
  83. SAUERBRUCH T, Mengel M, Dollinger M, Zipprich A, et al
    Prevention of Rebleeding from Esophageal Varices in Patients with Cirrhosis Receiving Small-diameter Stents vs Hemodynamically Controlled Medical Therapy.
    Gastroenterology. 2015 May 16. pii: S0016-5085(15)00683.
    PubMed     Text format     Abstract available


  84. CHARLTON M, Everson GT, Flamm SL, Kumar P, et al
    Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients with Advanced Liver Disease.
    Gastroenterology. 2015 May 15. pii: S0016-5085(15)00682.
    PubMed     Text format     Abstract available


    April 2015
  85. BETTAIEB A, Jiang JX, Sasaki Y, Chao TI, et al
    Hepatocyte NADPH Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.
    Gastroenterology. 2015 Apr 14. pii: S0016-5085(15)00509.
    PubMed     Text format     Abstract available


  86. LAMMERS WJ, van Buuren HR, Hirschfield GM, Hansen BE, et al
    Reply: To PMID 25160979.
    Gastroenterology. 2015;148:860-1.
    PubMed     Text format    


  87. NEUSCHWANDER-TETRI BA
    Targeting the FXR nuclear receptor to treat liver disease.
    Gastroenterology. 2015;148:704-6.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: